Wednesday, October 18, 2017

Gilead Gets FDA Approval for New Cancer Therapy

Gilead Sciences’ $11 billion bet on Kite Pharma is poised to pay off, with the approval of Kite’s flagship cell-therapy treatment for advanced lymphoma patients.

from WSJ.com: US Business http://ift.tt/2zllnBR
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)